Caroline Helwick[email protected]MRIBreast MRI pinpoints residual disease after chemotherapyBreast MRI accurately reflects the pathologic extent of residual disease following neoadjuvant chemotherapy, and tumor size and contrast kinetics measured by MRI may be useful early predictors of treatment response, according to a study presented at the San Antonio Breast Cancer Symposium.December 18, 2008Page 1 of 1Top StoriesMolecular ImagingSNMMI: Retreatment with Lu-177 PSMA-617 shows promise in mCRPC patientsRetreatment with Lu-177 PSMA-617 is emerging as a potential approach in men with prostate cancer.Nuclear MedicineSNMMI: New PET tracers developed for imaging brain disordersMolecular ImagingSNMMI: SPECT/CT valuable after Lu-177 therapyWomens ImagingDL model improves detection of breast arterial calcificationsSponsor ContentJoin Us June 26 at 12 Noon ET for a FREE webinar!